Skip to main content
. 2012 Apr 28;62(2):259–271. doi: 10.1136/gutjnl-2011-301585

Figure 5.

Figure 5

In vivo bioluminescence monitoring of orthotopic HT29.hCG.Luc tumours. All groups treated with topotecan mono- or combination therapy showed a slower increase in bioluminescence signal. pazo, pazopanib; topo, topotecan; UFT, uracil/tegafur.